Recruiting
Camrelizumab in Combination With Apatinib Mesylate Plus Short-course Chemotherapy for Advanced ESCC
NCT05738434
- Conditions
- Esophageal Cancer by AJCC V8 Stage
- Locations
-
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China